Thrombospondin expression in myofibers stabilizes muscle membranes

  1. Davy Vanhoutte
  2. Tobias G Schips
  3. Jennifer Q Kwong
  4. Jennifer Davis
  5. Andoria Tjondrokoesoemo
  6. Matthew J Brody
  7. Michelle A Sargent
  8. Onur Kanisicak
  9. Hong Yi
  10. Quan Q Gao
  11. Joseph E Rabinowitz
  12. Talila Volk
  13. Elizabeth M McNally
  14. Jeffery D Molkentin  Is a corresponding author
  1. University of Cincinnati, United States
  2. Emory University, United States
  3. Northwestern University, United States
  4. Temple University School of Medicine, United States
  5. Weizmann Institute of Science, Israel

Abstract

Skeletal muscle is highly sensitive to mutations in genes that participate in membrane stability and cellular attachment, which often leads to muscular dystrophy. Here we show that Thrombospondin-4 (Thbs4) regulates skeletal muscle integrity and its susceptibility to muscular dystrophy through organization of membrane attachment complexes. Loss of the Thbs4 gene causes spontaneous dystrophic changes with aging and accelerates disease in 2 mouse models of muscular dystrophy, while overexpression of mouse Thbs4 is protective and mitigates dystrophic disease. In the myofiber, Thbs4 selectively enhances vesicular trafficking of dystrophin-glycoprotein and integrin attachment complexes to stabilize the sarcolemma. In agreement, muscle-specific overexpression of Drosophila Tsp or mouse Thbs4 rescues a Drosophila model of muscular dystrophy with augmented membrane residence of βPS integrin. This functional conservation emphasizes the fundamental importance of Thbs' as regulators of cellular attachment and membrane stability and identifies Thbs4 as a potential therapeutic target for muscular dystrophy.

Article and author information

Author details

  1. Davy Vanhoutte

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8147-6953
  2. Tobias G Schips

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Jennifer Q Kwong

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jennifer Davis

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Andoria Tjondrokoesoemo

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Matthew J Brody

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Michelle A Sargent

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Onur Kanisicak

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Hong Yi

    Robert P. Apkarian Integrated Electron Microscopy Core, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Quan Q Gao

    Center for Genetic Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Joseph E Rabinowitz

    Temple University School of Medicine, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Talila Volk

    Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  13. Elizabeth M McNally

    Center for Genetic Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Jeffery D Molkentin

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    For correspondence
    jeff.Molkentin@cchmc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3558-6529

Funding

Howard Hughes Medical Institute (Molkentin)

  • Jeffery D Molkentin

National Institutes of Health (award P01NS072027)

  • Jeffery D Molkentin

National Institutes of Health (award R01HL105924)

  • Jeffery D Molkentin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Cincinnati Children's Hospital Medical Center (Protocol# IACUC2013-0013). No human subjects or human tissue was directly used in experiments in this study.

Copyright

© 2016, Vanhoutte et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,544
    views
  • 658
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Davy Vanhoutte
  2. Tobias G Schips
  3. Jennifer Q Kwong
  4. Jennifer Davis
  5. Andoria Tjondrokoesoemo
  6. Matthew J Brody
  7. Michelle A Sargent
  8. Onur Kanisicak
  9. Hong Yi
  10. Quan Q Gao
  11. Joseph E Rabinowitz
  12. Talila Volk
  13. Elizabeth M McNally
  14. Jeffery D Molkentin
(2016)
Thrombospondin expression in myofibers stabilizes muscle membranes
eLife 5:e17589.
https://doi.org/10.7554/eLife.17589

Share this article

https://doi.org/10.7554/eLife.17589

Further reading

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.

    1. Cell Biology
    Chun-Wei Chen, Jeffery B Chavez ... Bruce J Nicholson
    Research Article Updated

    Endometriosis is a debilitating disease affecting 190 million women worldwide and the greatest single contributor to infertility. The most broadly accepted etiology is that uterine endometrial cells retrogradely enter the peritoneum during menses, and implant and form invasive lesions in a process analogous to cancer metastasis. However, over 90% of women suffer retrograde menstruation, but only 10% develop endometriosis, and debate continues as to whether the underlying defect is endometrial or peritoneal. Processes implicated in invasion include: enhanced motility; adhesion to, and formation of gap junctions with, the target tissue. Endometrial stromal (ESCs) from 22 endometriosis patients at different disease stages show much greater invasiveness across mesothelial (or endothelial) monolayers than ESCs from 22 control subjects, which is further enhanced by the presence of EECs. This is due to the enhanced responsiveness of endometriosis ESCs to the mesothelium, which induces migration and gap junction coupling. ESC-PMC gap junction coupling is shown to be required for invasion, while coupling between PMCs enhances mesothelial barrier breakdown.